Hydrochlorothiazide Tablet
Product Images NDC 0480-3444

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0480-3444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of Hydrochlorothiazide, showing its molecular framework with sulfonamide groups, a chlorine atom, and a bicyclic ring system consistent with the active ingredient in Hydrochlorothiazide tablets.*

FDA Label Image

12.5 mg, 1000ct (Image 2)

Packaging label for Hydrochlorothiazide Tablets USP 12.5 mg, oral tablets by Teva Pharmaceuticals, Inc. The label includes the NDC 0480-3444-10 and states a package quantity of 1,000 tablets. It provides storage instructions and manufacturer details, listing manufacturing in the Czech Republic and distribution from Parsippany, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.